Navigation Links
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
Date:5/15/2013

LAVAL, Quebec, May 15, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that Dr. Laurence Paul has resigned from Valeant's Board of Directors due to expanded business, philanthropic, and personal commitments. Dr. Paul was originally elected to Biovail Corporation's Board of Directors in June 2002 where he served in several capacities, including heading at various times the audit and compensation committees and multiple special committees including the one that oversaw Biovail's side of the merger with Valeant in September 2010.  Since the merger, Dr. Paul has been a member of the Nominating and Corporate Governance Committee, the Operations Committee and the Compensation Committee and has been a key member of and previously headed the Finance and Transactions Committee. 

"We want to thank Larry for more than a decade of service to the Company, first at Biovail and then, as part of the new Valeant Board," stated J. Michael Pearson , chairman and chief executive officer.  "Larry has been a superb Board member for Valeant, investing his valuable time, talent, and passion to help transform Biovail and Valeant into a leading pharmaceutical company.   Larry's wise counsel will be missed."

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

 


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2018)... , ... December 13, 2018 , ... ... it’s essential that new and established organizations, as well as top talent, have ... potential risks that accompany them. , Through years of working hand-in-hand with ...
(Date:12/13/2018)... ... December 13, 2018 , ... Bladder issues are complicated and ... symptoms. Women’s Excellence now offers all bladder testing in office to be ... potassium sensitivity testing, and ultrasounds. Women’s Excellence is able to treat patients ...
(Date:12/13/2018)... ... December 13, 2018 , ... ... to patients. Women’s Excellence utilizes the GE Voluson E6 ultrasound to provide ... so that we can stay at the forefront of innovation and technological offerings ...
Breaking Medicine Technology:
(Date:12/13/2018)... ... ... New research out of Roswell Park Comprehensive Cancer Center shows that cancer patients ... survive than those who are sedentary, adding to the growing body of evidence that ... results were published in a recent issue of the journal Cancer Causes & Control. ...
(Date:12/13/2018)... ... 2018 , ... Evergreen Healthcare Partners is happy to welcome ... years of leadership experience in healthcare technology, consulting, project management and sales to ... creating vibrant cultures of personal growth and development. In her role as SVP ...
(Date:12/13/2018)... ... December 13, 2018 , ... Mediaplanet today announces the launch of this December’s ... organ transplantation while encouraging readers to sign up as an organ and/or whole-body donor ... lifesaving organ transplant. , One organ donor can save up to 8 lives, however, ...
(Date:12/10/2018)... ... December 10, 2018 , ... In the aftermath of 1960s feminist movement, multiple ... reinforced by the Me Too movement. To redress the balance, author Steve Clarke wrote ... and become the Men they were always meant to be by highlighting the qualities ...
(Date:12/10/2018)... , ... December 10, 2018 , ... The most active ... -- will once again host the CWCBExpo (Cannabis World Congress) leading B2B trade shows ... CWCBExpo New York, May 29-June 1, 2019, Jacob K. Javits Convention Center, New York, ...
Breaking Medicine News(10 mins):